Skip to content
healthcare.dev

TEZRULY

NDC 70954-592, Terazosin, solution, from ANI Pharmaceuticals, Inc..

Product NDC
70954-592
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA218139
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-592 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TERAZOSIN HYDROCHLORIDE1 mg/mL

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
70954-592-1070954059210150 mL in 1 BOTTLE (70954-592-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/69582e0c-6569-490c-8c14-999f3750336f

Use it

Look up 70954-592 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-592 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-592. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.